Virginia Retirement Systems’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.39M Hold
46,731
0.01% 494
2025
Q3
$1.69M Sell
46,731
-3,000
-6% -$98.8K 0.01% 452
2025
Q2
$1.79M Hold
49,731
0.01% 434
2025
Q1
$1.96M Buy
+49,731
New +$1.67M 0.01% 378
2023
Q3
$292K Sell
34,900
-16,300
-32% -$227K ﹤0.01% 811
2023
Q2
$1.27M Sell
51,200
-29,100
-36% -$752K 0.01% 473
2023
Q1
$1.21M Buy
80,300
+21,900
+38% +$333K 0.01% 489
2022
Q4
$691K Buy
58,400
+5,200
+10% +$37.7K 0.01% 734
2022
Q3
$315K Buy
+53,200
New +$349K ﹤0.01% 939
2022
Q1
$142K Sell
14,900
-2,800
-16% -$32.4K ﹤0.01% 1077
2021
Q4
$336 Buy
+17,700
New +$460K ﹤0.01% 956
2021
Q2
Sell
-9,300
Closed -$448K 1137
2021
Q1
$448K Sell
9,300
-3,500
-27% -$168K ﹤0.01% 898
2020
Q4
$666K Sell
12,800
-15,900
-55% -$537K 0.01% 749
2020
Q3
$768K Sell
28,700
-50,500
-64% -$1.16M 0.01% 617
2020
Q2
$1.54M Sell
79,200
-37,000
-32% -$596K 0.02% 446
2020
Q1
$1.14M Buy
116,200
+25,800
+29% +$326K 0.02% 502
2019
Q4
$1M Buy
90,400
+53,000
+142% +$403K 0.01% 693
2019
Q3
$210K Buy
+37,400
New +$261K ﹤0.01% 1074

Other funds holding TGTX

Virginia Retirement Systems's TGTX Position: Q4 2025 in Review

Virginia Retirement Systems held its TG Therapeutics (TGTX) position steady in Q4 2025 at 46,731 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #494.

Virginia Retirement Systems first reported a position in TGTX in Q3 2019 and has held it in 18 quarters since. The position peaked at $1.96M in Q1 2025. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Virginia Retirement Systems held 46,731 shares of TG Therapeutics worth $1.39M as of Q4 2025.
  • Virginia Retirement Systems left its TG Therapeutics share count unchanged in Q4 2025.
  • TG Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #494 holding.
  • Virginia Retirement Systems first reported a position in TG Therapeutics in Q3 2019 and has held it in 18 quarters since.
  • Virginia Retirement Systems's TG Therapeutics position peaked at $1.96M in Q1 2025.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.